BRIEF published on 10/02/2026 at 19:29, 3 days 21 hours ago ABIONYX: Information on Capital and Voting Rights Euronext Paris Share Capital Voting Rights Shares ABIONYX
BRIEF published on 10/02/2026 at 19:29, 3 days 21 hours ago ABIONYX : Informations sur le Capital et les Droits de Vote Euronext Paris Droits De Vote Capital Social Actions ABIONYX
PRESS RELEASE published on 10/02/2026 at 19:24, 3 days 21 hours ago Inside Information / Other news releases ABIONYX Pharma releases monthly statement of total voting rights and shares forming the company's share capital in compliance with French regulations Shares French Regulations Biopharmaceutical Total Voting Rights ABIONYX Pharma
PRESS RELEASE published on 10/02/2026 at 19:24, 3 days 21 hours ago Informations privilégiées / Autres communiqués ABIONYX Pharma communique le nombre total de droits de vote et d'actions en circulation. La société se positionne comme acteur clé dans les soins intensifs avec des biothérapies innovantes Droits De Vote Actions Biothérapies ABIONYX Pharma Soins Intensifs
BRIEF published on 10/02/2026 at 07:05, 4 days 9 hours ago ABIONYX Pharma Settles Bond Amortization with Share Issuance Share Issuance ABIONYX Pharma Cash Runway Fenja Capital Bonds Amortization
BRIEF published on 10/02/2026 at 07:05, 4 days 9 hours ago ABIONYX Pharma règle l'amortissement de ses obligations par une émission d'actions Émission D'actions ABIONYX Pharma Fenja Capital Routine De Trésorerie Amortissement Des Obligations
PRESS RELEASE published on 10/02/2026 at 07:00, 4 days 9 hours ago Inside Information / Other news releases ABIONYX Pharma settles anticipated amortization payment under bonds financing agreement, issuing new ordinary shares to Fenja Capital and maintaining unchanged projected cash runway into Q4 2028 ABIONYX Pharma Cash Runway New Ordinary Shares Bonds Financing Amortization Payment
PRESS RELEASE published on 10/02/2026 at 07:00, 4 days 9 hours ago Informations privilégiées / Autres communiqués ABIONYX Pharma annonce un amortissement anticipé partiel de son Financement Obligataire, réservé à Fenja Capital II A/S, avec émission d'Actions Nouvelles Actions Nouvelles Financement Obligataire ABIONYX Pharma Amortissement Anticipé Fenja
BRIEF published on 09/23/2026 at 21:41, 12 days 19 hours ago ABIONYX : Résultats Semestriels 2026 et Stratégies Future Recherche Et Développement Trésorerie France 2030 ABIONYX Pharma Résultats Financiers 2026
BRIEF published on 09/23/2026 at 21:41, 12 days 19 hours ago ABIONYX: 2026 Half-Year Results and Future Strategies Research And Development Treasury France 2030 ABIONYX Pharma 2026 Financial Results
Published on 10/06/2026 at 16:45, 10 minutes ago Announces Extension for Closing of Private Placement of Convertible Promissory Notes
Published on 10/06/2026 at 16:30, 25 minutes ago Snipp Survey Finds AI is Reshaping the Shopper Journey, with 61.8% of AI Users Having Purchased After an AI Recommendation
Published on 10/06/2026 at 15:45, 1 hour 10 minutes ago Stagwell Launches New Global Media Agency, Stagwell Media
Published on 10/06/2026 at 15:00, 1 hour 55 minutes ago Napo Pharmaceuticals, a Jaguar Health Family Company, Sponsoring Intestinal Failure Panel Discussion at Pediatric Gastroenterology Conference in Abu Dhabi
Published on 10/06/2026 at 14:31, 2 hours 24 minutes ago Worksport (Nasdaq: WKSP) Books $2.92M August Orders; Annualized Order Run Rate Reaches $35M
Published on 10/06/2026 at 16:35, 20 minutes ago Viola Aleo Ltd: First in Financial Intermediation for Five Consecutive Years
Published on 10/06/2026 at 16:30, 25 minutes ago Original-Research: Evonik Industries AG (von Parmantier & Cie. GmbH): Hold
Published on 10/06/2026 at 16:30, 25 minutes ago Original-Research: LANXESS AG (von Parmantier & Cie. GmbH): Buy
Published on 10/06/2026 at 16:15, 40 minutes ago Eleving Group announces early voluntary redemption of its EUR 90,000,000 13% Senior Secured Bonds 2023/2028 (ISIN: DE000A3LL7M4)
Published on 10/06/2026 at 16:05, 50 minutes ago Rockwell Automation Expands SecureOT Managed Services to Support Fortinet Firewalls and Existing Customer Infrastructure
Published on 10/05/2026 at 22:12, 18 hours 43 minutes ago AXA - Elimination of the dilutive impact of Shareplan 2026
Published on 10/05/2026 at 22:12, 18 hours 43 minutes ago AXA - Elimination de l'effet dilutif de l'opération Shareplan 2026
Published on 10/05/2026 at 18:13, 22 hours 42 minutes ago Disclosure of shares outstanding and voting rights - 05.10.2026
Published on 10/05/2026 at 18:13, 22 hours 42 minutes ago Déclaration nombre d'actions et droits de vote - 05.10.2026
Published on 10/05/2026 at 18:00, 22 hours 55 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 30 septembre 2026
